Found: 1
Select item for more details and to access through your institution.
DGAT1 and DGAT2 Inhibitors for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management: Benefits for Their Single or Combined Application.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 16, p. 9074, doi. 10.3390/ijms25169074
- By:
- Publication type:
- Article